10 Results for "

Carfilzomib

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Carfilzomib" in MCE Product Catalog:

77
77 Publications Verification
Cat. No.: HY-10455
CAS No.: 868540-17-4
Purity:  99.95%
Synonyms: PR-171
Research Areas:  

Cancer

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-129225
CAS No.: 2138924-36-2
Purity:  99.71%
Research Areas:  

Cancer

WRR139 is a peptide vinyl sulfone involving in disease processes such as inflammation and cancer. WRR139 is also a cytosolic enzyme N-glycanase 1 (NGLY1) and Nrf1 inhibitor. WRR139 enhances Carfilzomib cytotoxicity against cancer cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99302
CAS No.: 2235419-62-0
Synonyms: BMS-931699 Antibody

Target:  

CD28

Research Areas:  

Inflammation/Immunology

Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is an anti-CD28 domain antibody antagonist. Lulizumab inhibits T-cell activation by selectively targeting the CD28 signal. In a sensitized non-human primate kidney transplantation model, when combined with Carfilzomib (HY-10455), Lulizumab can regulate immune cells and prolong the survival time of the graft .
loading...
    loading...
Cat. No.: HY-159127
CAS No.: 2836263-09-1
Target:  

Ras MEK PERK Apoptosis

Research Areas:  

Cancer

HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor with a Kd value of 0.083 nM. HRS-4642 inhibits the binding of KRAS G12D to SOS1 or RAF1, thereby blocking the downstream MEK-ERK signaling pathway. HRS-4642 promotes Apoptosis. HRS-4642 alone or combined with Carfilzomib (HY-10455) effectively shapes the tumor microenvironment. HRS-4642 has an anti-cancer effect on pancreatic and colorectal cancers carrying the KRAS G12D mutation .
loading...
    loading...
Cat. No.: HY-10455R
CAS No.: 868540-17-4
Synonyms: PR-171 (Standard)
Research Areas:  

Cancer

Carfilzomib (Standard) is the analytical standard of Carfilzomib. This product is intended for research and analytical applications. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.
loading...
    loading...
Cat. No.: HY-10455S
CAS No.: 1537187-53-3
Purity:  98.73%
Carfilzomib-d8 is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.
loading...
    loading...
Cat. No.: HY-I0510
CAS No.: 868540-16-3
Target:  

Drug Intermediate

Research Areas:  

Cancer

Carfilzomib intermediate-1 (Intermediate IV) is a key intermediate for Carfilzomib (HY-10455) synthesis .
loading...
    loading...
Cat. No.: HY-128903
CAS No.: 2055896-83-6
Purity:  96.58%
Research Areas:  

Cancer

MC-Val-Cit-PAB-carfilzomib iodide is a conjugate of the ADC toxin molecule and the linker. MC-Val-Cit-PAB-carfilzomib iodide is formed by connecting the irreversible proteasome inhibitor Carfilzomib (HY-10455) and the ADC linker MC-Val-Cit-PAB (HY-78738).
loading...
    loading...
Cat. No.: HY-Z0028
CAS No.: 1541172-75-1
Synonyms: Carfilzomib Impurity 2
Target:  

Drug Intermediate

Research Areas:  

Others

(S)-N-((S)-1-(((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-P11311
CAS No.: 1356828-46-0
Target:  

Proteasome

Research Areas:  

Cancer

NC-002, a cell-permeable peptide, is a Trypsin-like proteasome inhibitor without inhibition of lysosomal cysteine proteases. NC-002 is the epoxyketone derivative of Leupeptin (HY-18234). NC-002 sensitizes myeloma cells to Bortezomib (HY-10227) and Carfilzomib (HY-10455). NC-002 can be used for cancers research .
loading...
    loading...